NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2025
Back to search
Official data from USPTO
EVOTEC INDIGO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVOTEC INDIGO
ST13
US500000079304082Class
35, 42, 45
Filing
79304082
Registration
6733704
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/07/2025
Trademark type
Word
Nice classes
35, 42, 45
Filing date
12/21/2020
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
11/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
BETTS, MARCYA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Evotec International GmbH
Representatives
William E OBrien, Esq. OBrien Global Law
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical cost management services
Class 42
Medical and scientific research in the fields of neuroscienceoncologyimmunology and inflammationmetabolic diseases and complicationsrespiratory and anti-infective diseasesdermatologyhaematologyophthalmologyrare diseases; conducting clinical trials for others in the field of neuroscienceoncologyimmunology and inflammationmetabolic diseases and complicationsrespiratory and anti-infective diseasesdermatologyhaematologyophthalmologyrare diseases; clinical research in the field of neuroscienceoncologyimmunology and inflammationmetabolic diseases and complicationsrespiratory and anti-infective diseases but also in many other indications in the fields of dermatologyhaematologyophthalmologyrare diseases; pharmaceutical research services; medical and scientific research consultation pertaining to pharmacologytoxicologydrug metabolismpharmacokineticsbioanalysistablet compression; research of medicines; development of pharmaceutical preparationsformulationsdrug substancesdrug productsactive pharmaceutical ingredientsmedicines; research to develop pharmaceutical products; design and testing of new pharmaceutical products for others
Class 45
Consultation in the field of regulatory compliance with respect to the pharmaceutical and medical products of others; regulatory compliance consulting services as they apply to clinical trials and preclinical drug development
Publications
History of USPTO decisions and trademark events.
29 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/17/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/08/2022
FIMP
FINAL DISPOSITION PROCESSED
09/08/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/24/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2022
PUBO
PUBLISHED FOR OPPOSITION
03/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/16/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/16/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2022
RFNT
REFUSAL PROCESSED BY IB
08/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/08/2021
RFRR
REFUSAL PROCESSED BY MPU
07/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/24/2021
CNRT
NON-FINAL ACTION WRITTEN
06/23/2021
DOCK
ASSIGNED TO EXAMINER
06/16/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/11/2021
Continuous trademark protection
Get notified about every new filing that threatens EVOTEC INDIGO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.